25
https://pubmed.ncbi.nlm.nih.gov/38112379
The study identifies the kinase BUB1 as a direct target of the oncogenic transcription factor MYB in adenoid cystic carcinoma, and its pharmacological inhibition causes synthetic lethality in patient-derived cells and organoids.